Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Research analysts at HC Wainwright issued their Q1 2027 EPS estimates for shares of Xenon Pharmaceuticals in a report issued on Friday, August 7th. HC Wainwright analyst D. Tsao forecasts that the biopharmaceutical company will post earnings of ($1.21) per share for the quarter. The consensus estimate […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | HC Wainwright Weighs in on Nuvation Bio Q1 Earnings | 0 | 9.79 | 10-08-2026 |
| 2 | HC Wainwright Has Weak Forecast for Cytosorbents Q1 Earnings | 0 | 11.13 | 10-08-2026 |
| 3 | FY2027 Earnings Forecast for Ardelyx Issued By HC Wainwright | 0 | 13.4 | 10-08-2026 |
| 4 | HC Wainwright Issues Pessimistic Forecast for OESX Earnings | 0 | 12.58 | 10-08-2026 |
| 5 | Equities Analysts Offer Predictions for Quantum Q1 Earnings | 0 | 11.48 | 10-08-2026 |
| 6 | XFOR FY2029 EPS Boosted by Brookline Capital Markets | 0 | 12.66 | 10-08-2026 |
| 7 | HC Wainwright Weighs in on Delcath Systems Q1 Earnings | 0 | 10.45 | 10-08-2026 |
| 8 | HC Wainwright Estimates McEwen’s FY2026 Earnings (NYSE:MUX) | 0 | 12.67 | 10-08-2026 |
| 9 | HC Wainwright Forecasts Higher Earnings for Biomea Fusion | 0 | 9.98 | 10-08-2026 |
| 10 | FY2029 Earnings Estimate for AMLX Issued By HC Wainwright | 0 | 11.9 | 10-08-2026 |